NASDAQ:SYBX Synlogic Q4 2024 Earnings Results & Report $0.98 0.00 (0.00%) As of 11/18/2026 11:03 AM Eastern Synlogic beat analyst earnings expectations in its Q4 2024 results, released March 6, 2025. The company reported EPS of -$0.06 versus the -$0.10 consensus estimate. Research:ProfileEarnings History Earnings Announcement Details QuarterQ4 2024Report DateMarch 6, 2025TimeAfter Market ClosesConference Call8:30 AM ET Synlogic EPS ResultsActual EPS-$0.06Consensus EPS -$0.10Beat/MissBeat by +$0.04One Year Ago EPSN/AEPS Beat Rate4 of last 8 quartersSynlogic Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesAnnual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsAnnual report(10-K) Synlogic Q4 2024 Earnings FAQ Did Synlogic beat earnings estimates for Q4 2024? Synlogic (NASDAQ:SYBX) reported earnings of -$0.06 per share for Q4 2024, beating the consensus estimate of -$0.10. The report was announced on Thursday, March 6, 2025. Synlogic Earnings HeadlinesSynlogic (SYBX) Set to Post Earnings on WednesdayNovember 10, 2026 | americanbankingnews.comBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Varex Imaging Corporation (Nasdaq – VREX), Synlogic, Inc. (OTC – SYBX), Bowman Consulting Group Ltd. (Nasdaq – BWMN), Nathan's Famous, Inc. (Nasdaq – NATH)August 28, 2026 | globenewswire.comMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.November 19 at 1:00 AM | Weiss Ratings (Ad)SYBX Stock Alert: Halper Sadeh LLC is Investigating Whether Synlogic, Inc. is Obtaining a Fair Price for its ShareholdersAugust 10, 2026 | tmcnet.comSynlogic and Caldera Therapeutics announce merger and $278 million private placementJuly 29, 2026 | msn.comSynlogic Challenges Nasdaq Delisting NoticeNovember 26, 2025 | tipranks.comSee More Synlogic Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Synlogic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Synlogic and other key companies, straight to your email. Email Address About SynlogicSynlogic (NASDAQ:SYBX) is a biotechnology company that has focused on developing “synthetic biotics”—engineered bacteria designed to perform therapeutic functions in the body. Its approach uses synthetic biology to modify microbes so they can produce or consume specific substances, with the aim of treating disease. The company’s research has centered on rare metabolic disorders, including phenylketonuria (PKU) and homocystinuria. Its investigational programs were designed to help break down compounds that build up in people with these conditions. Synlogic has not been known for marketed medicines; its work has been primarily in research and clinical development. Founded in 2013 as a spinout from the Massachusetts Institute of Technology, Synlogic has been based in Cambridge, Massachusetts. Its programs and platform have been directed mainly toward the development of treatments for patients with metabolic diseases.View Synlogic ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play ItLowe's Earnings Beat Looked Strong Until a 34-Cent Tariff Refund Changed the MathApple's Next Margin Defense Could Be Hiding in Your WalletThe Uranium Price Paradox: 5 Investments Facing Very Different Tests in 2027Target Stock Is Up Over 70%—Has the Easy Money Already Been Made? Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.